Methods of use of cyclopamine analogs
US-9669011-B2 · Jun 6, 2017 · US
US11007181B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11007181-B2 |
| Application number | US-201916521447-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 24, 2019 |
| Priority date | Dec 28, 2006 |
| Publication date | May 18, 2021 |
| Grant date | May 18, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides derivatives of cyclopamine having the following formula:
Opening claim text (preview).
It is claimed: 1. A hydrochloric acid salt of a compound having the structure: wherein the hydrochloric acid salt is in the form of an iso-propanol solvate. 2. A pharmaceutical composition comprising the hydrochloric acid salt of claim 1 and a pharmaceutically acceptable excipient.
spiro-condensed · CPC title
condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline · CPC title
Spiro-condensed systems · CPC title
containing purines, e.g. adenosine, adenylic acid · CPC title
Ortho-condensed systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.